Chances of contracting flu or swine flu, or some seasonal influenza are much greater than the chances of getting the new Coronavirus. Consequently, if you have some variant of flu, then it might not be wise to make a beeline for some hospital treating numerous Coronavirus patients, when there is such a place and they have such patients. You are more likely to catch the disease at the hospital than anywhere else in Ukraine.
It is really hard to judge the mortality rate as many if not most who contract it, don't report it or seek medical treatment and only a few flu patients who report having been in China are probably tested with the very few test kits available.
There is a lot of bias in the media, though, because if you consider all forms of influenza, in the U.S., about 64,000 die of influenza each flu season. One person has died of Coronavirus this year, but that justifies a panic and regular flu does not.
Yes, in some form, the Coronavirus will eventually spread everywhere, but:
Any kind of Virus, particularly the sort we are discussing, mutates rapidly, and what eventually will spread successfully in Ukraine or the U.S. will not be the same as what is going on in Wuhan.
A rule of thumb is that viruses can either evolve to be more deadly or they can evolve to be more contagious, but not both. That's because natural selection favors viruses that do not kill their victims. Dead people are not the ideal Typhoid Mary(s) for a virus. So, the virus that killed people in Wuhan is more likely to be contained, and similar versions that are more likely to spread and less likely to kill are more likely to make it to Ukraine or to America. The chances of a weak form dominating, increase with time. So, while we will all get Coronavirus, by the time it gets to us, it is probably going to be weaker. In 1.5 years vaccines will be widely available. Some laboratories have already made test batches of vaccine and will begin testing shortly. Many countries will be testing vaccines within a few weeks. The U.S. has already created a vaccine and it might be rushed to approval in just a year and a half or so. Other countries with less burdensome regulation, like Israel, might have a vaccine on the market, in small batches, in less than six months. Once an even moderately effective vaccine is available to even just the elderly, the crisis is over in the country that distributes it.
